Statistics
The Estrella Immunopharma stock price is currently $ 0.08780 with a total market cap valuation of $ 27.84M (317.09M shares outstanding). The Estrella Immunopharma is trading on NASDAQ under the ticker sign ESLAW. Estrella Immunopharma price is up
Description
Estrella Immunopharma, Inc. is an early-stage biopharmaceutical firm based in Emeryville, California, dedicated to advancing T-cell immunotherapies for various hematological malignancies and solid tumors within the United States. Its lead investigational treatments include EB103, currently undergoing preclinical assessment for diffuse large B-cell lymphoma, and EB104, which targets both diffuse large B-cell lymphoma and acute lymphocytic leukemia. The company also collaborates with Imugene Limited to develop solid tumor therapies, integrating Imugene's candidate CF33-CD19t with Estrella's EB103.
Company Profile
- Full Name: Estrella Immunopharma
- Sector: Healthcare
- Website: https://www.estrellabio.com
